Figure 1
ERIC-PPCI study flowchart. Flowchart in black represents the ERIC-PPCI main study, whereas in blue represents the thrombosis substudy. Blood samples were taken at three time points: (i) baseline upon arrival to the catheterization laboratory and at randomization, (ii) at clinical stabilization, just prior to hospital discharge, and (iii) at 6–8 weeks of follow-up. NSAEs, non-serious adverse events; PIS, patient information sheet; SAEs, serious adverse events.

ERIC-PPCI study flowchart. Flowchart in black represents the ERIC-PPCI main study, whereas in blue represents the thrombosis substudy. Blood samples were taken at three time points: (i) baseline upon arrival to the catheterization laboratory and at randomization, (ii) at clinical stabilization, just prior to hospital discharge, and (iii) at 6–8 weeks of follow-up. NSAEs, non-serious adverse events; PIS, patient information sheet; SAEs, serious adverse events.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close